Table 1:

Baseline Characteristics by Degree of Neutropenia

	None (n=125)	Mild (n=42)	Moderate (n=34)	Severe (n=25)	p-value
Recipient Age, years, mean (SD)	54.3 (13.0)	53.7 (12.3)	49.9 (13.4)	49.2 (15.8)	0.287
Recipient Gender					0.135
Female	44 (35.2)	18 (42.9)	13 (38.2)	15 (60)
Male	81 (64.8)	24 (57.1)	21 (61.8)	10 (40)
Recipient Race					0.528
White	118 (94.4)	38 (90.5)	32 (94.1)	25 (100)
African-American	5 (4)	4 (9.5)	2 (5.9)	0 (0)
Asian	2 (1.6)	0 (0)	0 (0)	0 (0)
Transplant Diagnosis					0.570
ILD	62 (49.6)	21 (50)	13 (38.2)	11 (44)
COPD	30 (24)	12 (28.6)	6 (17.6)	4 (16)
CF	16 (12.8)	7 (16.7)	9 (26.5)	8 (32)
A1AT	5 (4)	1 (2.4)	2 (5.9)	0 (0)
PH	2 (1.6)	0 (0)	1 (2.9)	0 (0)
Other	10 (8)	1 (2.4)	4 (8.8)	2 (8)
Recipient CMV Positive	75 (60)	23 (54.8)	14 (41.2)	15 (60)	0.258
Donor Age, years, mean (SD)	35.9 (14.9)	34.6 (13.3)	38.9 (14.9)	39.8 (16)	0.771
Donor Male Gender	85 (68)	27 (64.3)	20 (58.8)	14 (56.0)	0.585
Donor Race					0.184
White	101 (80.8)	33 (78.6)	20 (58.8)	20 (80)
African-American	23 (18.4)	9 (21.4)	14 (41.2)	5 (20)
Asian	1 (0.8)	0 (0)	0 (0)	0 (0)
CMV Mismatch Status
R−/D−	28 (22.4)	8 (19)	3 (8.8)	2 (8)
R+/D+	51 (40.8)	21 (50)	8 (23.5)	11 (44)
R+/D−	24 (19.2)	2 (4.8)	6 (17.6)	4 (16)	0.005
R−/D+	22 (17.6)	11 (26.2)	17 (50)	8 (32)
Transplant Type					0.622
Single	6 (4)	0 (0)	1 (2.9)	1 (4)
Bilateral	119 (96)	42 (100)	33 (97.1)	24 (96)
Ischemic Time, minutes, mean (SD)	278.2 (67.6)	264.3 (73.6)	289 (65.8)	288.1 (80.3)	0.322
Induction Therapy					0.007
Basiliximab	81 (65.3)	27 (64.3)	26 (76.5)	18 (72)
ATGAM	42 (33.9)	9 (21.4)	6 (17.6)	5 (20)
Thymoglobulin	0 (0)	2 (4.8)	0 (0)	0 (0)
Other	1 (0.8)	3 (7.1)	1 (2.9)	1 (4)
None	0 (0)	1 (2.4)	1 (2.9)	1 (4)
PGD @ 72hours					0.602
0	54 (43.2)	11 (26.2)	10 (29.4)	10 (40)
1	60 (48)	26 (61.9)	20 (58.8)	11 (44)
2	8 (6.4)	4 (9.5)	2 (5.9)	3 (12)
3	3 (2.4)	1 (2.4)	2 (5.9)	1 (4)